4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000324
Options or other derivatives
- Chief Financial Officer acquired 178,768 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Stanker James H Chief Financial Officer | 2022-12-31 | Grant or award · Restricted Stock Units | −12,951 | 352,614 | D | ||
| Stanker James H Chief Financial Officer | 2023-01-01 | Grant or award · Restricted Stock Units | −69,667 | 422,281 | D | ||
| Stanker James H Chief Financial Officer | 2023-01-01 | Grant or award · Restricted Stock Units | −96,150 | 518,431 | D | ||
Loading xslF345X03/doc1.xml…